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Abstract
Patient pathways are recognized as a valuable tool
to support standardization, comparability, quality, and
transparency of care processes in comprehensive care
networks. Still, existing development approaches lack
real practical guidance as well as an integration of the
network and patient perspectives. Therefore, a usercentered and requirements-based approach was chosen
to design a patient pathway development method. It
defines a role model and procedural steps. The method’s
innovative character lies in the development of generic
patient pathway templates to be adapted to national,
regional, and local conditions of specific
comprehensive care networks. The method was
positively assessed in terms of demonstrating its
applicability and the fulfilment of user requirements
with a use case from oncology care – the development
of a colorectal cancer patient pathway template. This
work drives the standardization of patient pathway
development and their large-scale implementation in
comprehensive care networks, supporting the analysis,
design, and optimization of healthcare processes.

1. Introduction
Patient pathways are used to plan and manage the
whole process of care for a specific patient type,
especially for patients with complex, long-term
conditions, by defining goals and milestones while also
supporting mutual decision-making by the patient and
her/his multidisciplinary care team collaborating in a
comprehensive network of care providers [1]–[3].
Against the background of an increasing demand for
integrated care delivery in a coordinated network of
health service providers [4], [5], the concept of patient
pathways becomes even more important. For example,
in cancer care - with cancer being one of the most
common and costly diseases in western countries [6] patient pathways are regarded as important tools to
improve patient information, to implement evidenceURI: https://hdl.handle.net/10125/71071
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based medical guideline recommendations as well as to
support seamless, optimal care in a comprehensive
network of different health service providers [7].
However, uniform and standardized practical support
for the development of patient pathways is not given yet.
There are different procedural frameworks for the
development and implementation of pathways (e.g. [8]–
[13]), but they are rather generic and not described in
such detail as to provide practical guidance and support
for the users. Also, pathway development is mostly
addressed for single health care institutions, not the
entire care network involved in the care process of
patients. Also, the clinical rather than the patient
perspective is the focus so far (e.g. [1], [14]).
To centrally support network governance, e.g. by
national or international non-profit organizations, and to
increase the quality of care across care networks, a
template-based patient pathway development approach
is called for [9]. Patient pathway templates for particular
patient types can function as guiding blueprints for the
development of network-specific ones by adapting them
to national, regional, and local specifics (e.g. availability
of technologies or national guidelines on follow-up
timeframes). This approach would allow for better
comparability, consistency, and increased uniformity of
care provision across different comprehensive care
networks [9]. Also, similar to the general advantages of
reference models [15], an increase of safety for patients
and health service providers, the reduction of risks and
costs during pathway development (e.g. by shortening
the development time), and an increase of pathway
quality can be expected. Still, the potentials of reusable
patient pathway templates are not exploited yet.
Addressing these gaps and elaborating on the
template-based patient pathway approach, this paper
aims to provide practical guidance with a method for the
development of patient pathways in comprehensive care
networks. The focus is on the construction and design of
patient pathway templates and on highlighting the
network and patient view. Therefore, a user-centered
and use-case-driven approach is chosen.
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The remainder of the paper is structured as follows.
In section 2, the used methods are described. The
requirements analysis for practical guidance of patient
pathway development is conducted in section 3. Based
on this and to practically guide the development of
patient pathways, a procedural model and a role model
for a patient pathway development method, hereafter
abbreviated with Pa2D-method, are described in section
4. In section 5, the method is assessed in terms of
demonstrating its applicability and demonstrating the
fulfillment of user requirements with an example use
case in oncology care. The paper closes with a
discussion and a conclusion in sections 6 and 7.

requirements were used to develop the Pa2D-method.
We demonstrate its applicability with the development
of a colorectal cancer patient pathway template for
comprehensive cancer care networks. The experiences
during the application were used to assess the method
and to derive lessons for improvement. The
development team of the colorectal cancer template was
asked to answer an online questionnaire. It addressed the
degree of fulfilling the defined requirements with the
Pa2D-method as well as for the personal (positive and
negative) perception of the application of the method.

2. Method

The analysis of the user stories resulted in the
identification of functional and non-functional
requirements which cover both general procedural
issues as well as the representation of patient pathways.
Functional requirements describe the desired functions
of the intended patient pathway development method.
We identified seven functional requirements R1 to R7.
They are described in the following. An exemplary user
story for each requirement is given in Table 1.
R1 - Patient pathways for comprehensive care
networks should have uniform template character and
provide adaptation notes for their implementation to
particular care networks. The development method
should produce generic patient pathway templates, i.e.
standard pathway patterns, which are not specific for a
particular care network but provide a framing of
essential building blocks for each phase of care for a
specific disease. The templates function as guidance for
the development of network-specific patient pathways
and provide adaptation notes for implementation, e.g.
required/optional parts or adaptation instructions
considering national, regional, or local conditions.
R2 - Patient pathways should be disease-specific.
They should be designed for a specific patient type, e.g.
patients with a specific tumor entity, and thus describe
in- and exclusion criteria for entering the pathway.
R3 - Patient pathways should be developed by a
multi-stakeholder working group. This means, they
should be developed by a working group consisting of
people representing the roles and organizations involved
in care provision along the whole pathway. This should
also include the patient perspective.
R4 - A patient pathway development method should
define the group processes. This includes for example
the definition of group composition, roles, consensus
finding, decision-, prioritization- and review processes.
R5 - Patient pathways should be developed based on
scientific evidence, especially medical guideline

For the design and testing of a patient pathway
development method for comprehensive care networks,
the design science paradigm was followed [16]. With
the aim to provide a user-centered and practical method,
we used a qualitative data collection approach by
defining user requirements based on user stories. A user
story is a statement written from the end user’s
perspective [17]. It represents a short, informal
description of a requirement in the format “As a <role>
I want <something> so that <benefit>.” We set up a
workshop and asked 25 people to describe user stories
from their own or a chosen perspective, i.e. role. The
workshop included international participants who are
part of an international project consortium in the domain
of cancer care. The group consisted of health care
providers (e. g., oncologists, nurses), managers of health
care organizations, methodologists (e. g., medical
guideline developers), representatives of national
authorities and international and national health
organizations, patient representatives as well as
researchers. The participants were given the example
user story “As a physician in a patient pathway
development board I want to use an agreed upon
pathway representation format so that all colleagues in
[comprehensive cancer care networks] can exchange
pathways across networks”. Altogether, 33 user stories1
were collected. They were analyzed using a qualitative
content analysis according to Mayring [18] with a
coding scheme derived from a previous systematic
literature review of existing pathway methods
conducted by the authors [9]. Therewith, we derived
requirements for the intended patient pathway
development method. We focused on construction- and
design-related requirements which specify the
development phase for patient pathways. The roles
specified in the user stories together with the derived
1

3. Requirements analysis

The full list of user stories can be provided by the authors.
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recommendations. The link of the patient pathway
content to its evidence base should be maintained.
Therefore, patient pathways should provide concepts to
describe the evidence level of a recommendation (e.g.
pathway step/decision) and to link the evidence source.
R6 - A patient pathway should sequence obligatory
and optional steps and the relevant information along
all phases of care in a comprehensive care network for
the involved care providers and the patient. Relevant
information are tasks, decisions, roles, process flows,
time restrictions, information objects, quality aspects.
R7 - Patient pathways should provide a patient view
to
support
shared
decision-making
and
individualization. They should represent steps the
patient is directly involved in (e.g. consultation,
consent) or has to perform him-/herself. They should
allow for individualization to patient-specific situations,
e.g. patient preferences or comorbidities.
Table 1. Functional requirements
No. Example user story
R1 “As a manager I want the methodology to
provide guidelines on the pathway development
and identify the essential building blocks of a
pathway so that pathways can be developed and
adopted to the local healthcare context of the
[comprehensive care network].”
R2 “As a medical doctor in training I want patient
pathways to be tumor-specific so that I can
provide quality of care.”
R3 “As a patient I want patient views and
perspectives to be integrated in the [pathway
development] process in order to integrate
shared (informed) decision-making in patient
pathway development.”
R4 “As a methodologist in a [patient pathway
development] board I want to have
information/agreement on consensus finding
process so that bias in [patient pathway
development] is controlled.”
R5 “As a methodologist in a [patient pathway
development] board I want to have a description
of the evidence base and the strength of
certainty in order to get transparent and
reproducible results.”
R6 “As national authority I want to have a mean to
define obligatory tasks within the pathway.”
R7 “As a patient I want a patient pathway that I can
understand and that helps me make decisions
together with my doctor and my family so that I
can be in control of what is happening and to
check if everything is going according to my
expectations […].”

Additionally, non-functional requirements were
identified. These specify criteria that can be used to
evaluate the method’s performance in terms of quality
criteria. A method to develop patient pathways for
comprehensive care networks should be generic, easyto-manage (workable), inclusive, and easy-tounderstand (e.g. “As a […] network advisor I want an
inspiring, workable, generic method for designing and
implementing patient pathways […]”). A standardized,
clear and easy-to-analyze representation format of
patient pathways should be used (e.g. “As a (healthcare)
researcher I want conceptually clear and ‘easy to
analyze’ […] representation so that it facilitates
efficient, transparent and reproducible research”).

4. Patient pathway development method
According to Brinkkemper (1996), “[a] method is an
approach to perform a systems development project,
based on a specific way of thinking, consisting of
directions and rules, structured in a systematic way in
development activities with corresponding development
products” [19]. Patient pathways are a processual view
of a comprehensive care network which is a sociotechnical system [20]. To systematically guide and
support their development, the Pa2D-method is
proposed. In the following, its role model and the
procedural model are described.

4.1. Roles
To specify the tasks and expected qualifications of
people applying the Pa2D-method, the involved roles are
summarized in Table 2.
To meet the requirement of template-based pathway
development (see R1, sec. 3), the roles patient pathway
template designer and patient pathway designer are
distinguished. The former develops the template and
prepares it for reuse whereas the latter adapts the patient
pathway template to national, regional, or local specifics
of a comprehensive care network. Both roles should be
modelling experts and experienced in the application of
process (pathway) modelling languages. The patient
pathway template designer additionally needs to be
familiar with reference modelling techniques, especially
pathway templates. Depending on the organizational
context, both roles can be assigned to one person.
For the development of a patient pathway template,
the knowledge input from domain experts of the specific
health care phenomenon, e.g. a health condition or
disease for which the patient pathway (template) shall
be developed, is necessary. The content of the patient
pathway template, e.g. activities, process-, information-
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Table 2. Role model of the Pa2D-method2
Task
Qualification
Patient pathway template designer
Ensures adequate use of the
Modelling expert:
modelling language; excerpts the computer
knowledge of the domain
scientist,
experts and transfers it into the
information
PP template; prepares PP
systems engineer
templates for reuse
Patient pathway designer
Ensures the correct application
Modelling expert:
of the PP template; adapts the PP computer
template model to CCN
scientist,
specifics; models the PP
information
elements
systems engineer
Patient pathway template stakeholder
Gives domain input for PP
Domain expert:
template development; reviews
representative of
and approves PP template
interest group
contents and representation
Patient pathway user
Uses the developed, approved
Domain expert:
PP and implements it in the
representatives of
accounted CCN unit; supports
involved CCN
with the adaptation of the PP
units along the PP
template, e.g. to CCN specifics;
participates in approving the PP
for the CCN
Method expert
Is particularly familiar with
Method expert:
template-based pathway design; business
leads the execution of the
economist,
method and conducts necessary information
trainings on the method;
systems engineer
recognizes and implements
change requests to the method;
involves in the continuous
optimization of the method
or resource flows, involved roles, obligatory and
optional parts, should be provided by a team of
representatives of different interest groups (see R3, sec.
3). These patient pathway template stakeholders should
involve health policy representatives (e.g. national
authorities, health policy developers, or advisors),
representatives of national or international health care
organizations or associations (e.g. representatives of
accreditation organizations or medical guideline
development), researchers, and representatives of
involved units of comprehensive care networks (e.g.
network managers, quality managers, healthcare

professionals). To also explicitly include the patient
perspective (see R7, sec. 3), representatives of patient
organizations should be involved in the patient pathway
template development.
Patient pathway templates are applied to specific
comprehensive care networks. The adaptation of the
template is supported by patient pathway users, who are
familiar with the specific characteristics of the own
comprehensive care network. Also, they implement the
approved patient pathway. The patient pathway users
primarily are medical, nursing, and supportive care
professionals. Also, administrative staff and the patient
him-/herself are relevant representatives. Thus, patient
pathway users are a subgroup of patient pathway
template stakeholders and people could be assigned both
roles at the same time.
The quality and progress of the patient pathway
development process should be assured and monitored
by a method expert. This role also includes the
responsibility for the training and guidance of the
project team members in terms of the Pa2D-method.

4.2. Procedural model
A typical project flow for the development and
implementation of template-based patient pathways in
comprehensive care networks consists of the main
phases as shown in Figure 1. The process consists of two
major parts, which are first, the development of a
generic patient pathway template for a specific disease
(see upper part of Figure 1) and second, the templatebased development of patient pathways for a particular
comprehensive care network by adapting the template to
national, regional, and local context (see lower part of
Figure 1). This distinction is in particular due to
requirement R1 (see sec. 3).
The project institution for template development
comprises the establishment of the multidisciplinary
patient pathway template development team (working
group) [8], [10], [13], [21]. In detail, this team shall
consist of patient pathway template designer(s), patient
pathway template stakeholders including patient
pathway users, and method expert(s) as described in the
Pa2D-method’s role model in section 4.1. Also, the team
shall be trained and educated about the development
process [8], [13] and the consensus finding process shall
be defined [9] (see R3 and R4, sec. 3). The project plan,
e.g. timetables, tasks, responsibilities, and resources,
should be set up [10], [13]. The definition of the
addressed patient population is necessary.

2

“Patient pathway” is abbreviated with PP and “comprehensive care
network” with CCN in Tables and Figures of this article.
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Development of generic
patient pathway template
Template-based development of
CCN-specific patient pathway

Project institution
for template
development

Systematic
collection and
review of evidence

Patient Pathway
template
construction

Dissemination

Patient Pathway
template
repository

Project institution
for pathway
development

Adaptation of the
template to CCN
context

Implementation
and evaluation of
pathway in CCN

Figure 1. Main phases of the Pa2D-method for
the development of generic templates and
their adaptation in CCNs
The systematic collection and review of evidence
should use literature reviews to analyze and assess the
current state of existing evidence for the whole
continuum of care covered by the patient pathway [8],
[10], [11], [21] (see R2 and R3, sec. 3). This step should
also include a review of existing patient pathways for
the addressed patient type in the scientific and grey
literature, e.g. published by healthcare organizations. In
this context, similar concepts such as care pathway,
clinical pathway, or patient journey should be included
in the search as well since they are often used
synonymously [2], [9]. The collection of evidence
should be carried out by the patient pathway template
stakeholders and methodologically supported by the
method expert. The collected literature and existing
pathways are input for the following template
construction phase.
The patient pathway template construction is the
core phase of the Pa2D-method and for this reason
highlighted in yellow in Figure 1. In Table 3, the
essential information of this phase is represented.
Table 3. External view on the phase “patient
pathway template construction”
Attribute Description
Objective Development of a reference PP template
in CCNs for specific patient population
Input
Current evidence (medical guidelines,
systematic reviews), existing pathways,
defined target patient population
Output
Approved and agreed upon PP template
Roles
PP template designer(s), PP template
involved
stakeholders, PP users, method experts
Customers CCNs applying the template
To practically guide the patient pathway template
construction, a more detailed procedural description is
provided. It consists of six steps, with the steps 2 to 5
being performed in an iterative manner (see Fig. 2). The

scope definition (1) includes the specification of the
phases along the continuum of care which are to be
covered by the patient pathway template. Such phases
are typically the network entry, prevention, diagnosis,
treatment planning, treatment, follow-up, rehabilitation,
supportive care, end-of-life care, and end of network
care. The patient population as well as in- and exclusion
criteria for patients entering the patient pathway need to
be defined. Also, the modeling language and tool need
to be selected [12]. The systematic literature review of
standard languages and notations for the graphical
modeling of patient care processes conducted by
Mincarone et al. [22] showed, that the Business Process
Model and Notation (BPMN) as well as the Unified
Modeling Language (UML), especially its activity and
use case diagrams, are well known and used approaches
in health care practice. Domain-specific modeling
language extensions such as BPMN4CP, a BPMN
extension for care pathway modeling [23], could be used
as well. Using this modeling language, the evidence
level and evidence source can easily be represented and
maintained within the pathway (template) model (see
R5, sec. 3) by the patient pathway (template) designer.
3
Detailing each
process candidate
input sheet

1
Scope definition

[process candidates]

2

Identification
of process
candidates

[detailed process candidates]

process landscape

[patient pathway template
under revision]

template modeling

internal and
external review

Evaluation of the
patient pathway
template
5

4
Designing the
patient pathway
template model

[patient pathway template]

[template without
need for revision]

6
Final approval

Figure 2. Inner view of the phase “patient
pathway template construction”
The next step is the identification of process
candidates (2), i.e. the identification of important
patient pathway steps (process candidates) and linking
them to the phases of care as defined in step (1). The
result is called the process landscape. Therefore, the
contents of existing pathways for the addressed patient
population – identified with the previously conducted
literature review – should be analyzed and mapped to
structure the patient pathway landscape. If there are
none available, this step can be solely performed in
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workshops with the domain experts and by including the
recommendations from medical guidelines.
After the process landscape of the patient pathway
template is defined, the detailing of each process
candidate (3) follows. Therefore, a standardized input
sheet is provided with the Pa2D-method. It roots in the
information collected for care pathway building as
described with the 3-blackboard method by Vanhaecht
et al. [24] but additionally includes perspectives to be
covered in order to meet the patient pathway specific
requirements from section 3. The sheets should be filled
in by the involved domain experts from the working
group and with the results of analyzing the
recommendations of medical guidelines and the articles
identified with the conducted review on current
evidence. To reduce the risk of distortion of included
studies, the level of evidence must be paid attention to
[25]. The input sheet is filled for each process candidate
and requires the following information: (a) process
name, (b) patient inclusion criteria (e.g. a subgroup of
the generally addressed patient population), (c)
responsible/ involved units of the comprehensive care
network, (d) resources (e.g. medical technology,
infrastructure), (e) process inputs (e.g. information, lab
results), (f) detailed process description (i.e.
interventions, decisions, consultations, tasks related to
medical, nursing, and supportive care (i.e.
psychological,
physical,
emotional,
practical/
organizational, informational, spiritual, social support
[26]), as well as to administration and activities the
patient is responsible for), (g) times (i.e. time
criticalities, time recommendations, iterations), (h)
process outputs, (i) measures/ evaluation criteria (e.g.
quality indicators to be assessed), (j) adaptation notes
(i.e. required and optional steps; national, regional, local
conditions to be considered for the implementation in a
specific comprehensive care network).
Using the information from the filled input sheets,
the next step is designing the patient pathway template
model (4) by the patient pathway template designer.
Therefore, the process landscape view is detailed by
specifying the process candidates, their order and
relations. This step can be supported by also including
methods for the derivation of pathways from medical
guideline recommendations (e.g. [27]). The template
designer might identify information gaps, which need to
be closed by getting feedback from the involved domain
experts. This can happen either on short notice or during
the following evaluation of the patient pathway template
(5). With this step, feedback from the working group is
collected and need for improvements of the template is
identified. Furthermore, the template should also be
reviewed by external domain experts, who were not
involved in its development. As long as there is need for
revision of the patient pathway template, the steps (2) to

(5) are performed in development cycles, detailing the
template in each iteration. When the patient pathway
template is evaluated with no need for further revisions,
it gets final approval (6) from the working group.
After final approval, the patient pathway template
for the specific disease should be disseminated and
published, i.e. made available to the comprehensive care
networks of interest. Therefore, a messaging and
dissemination strategy needs to be developed and
implemented [10], [11], [21]. With this regard, a
common patient pathway template repository, provided
and managed by a governing agency of the addressed
comprehensive care networks or an international health
care society, would be beneficial [9].
An approved patient pathway template can then be
implemented in comprehensive care networks. When a
network decides to develop a patient pathway based on
such template, it first needs to establish a project
institution for pathway development. This multidisciplinary project team should involve the patient
pathway users of the network, patient pathway
designer(s), and development method expert(s) as
described in the Pa2D-method’s role model in section
4.1. The task of the working group is the adaptation of
the template to the context of the comprehensive care
network, i.e. to national, regional, and local specificities
which are not part of the evidence base used for pathway
template development (medical guidelines). Therefore,
the adaptation notes specified with the template should
be used. Reasons for adaptation could for example be
national disease management programs or follow-up
plans defining timeframes of a follow-up routine. The
pathway also needs to be adapted in case of unavailable
technologies or care professionals (e.g. the role of nurse
specialists might differ between countries). After its
development, the patient pathway needs to be piloted,
implemented and continuously evaluated in the
comprehensive care network (see [9] for a detailed list
of steps necessary for this purpose, e.g. checking for
new evidence).

5. Demonstration and assessment
For the evaluation of the Pa2D-method, focusing on
the template construction phase, we first, demonstrate
its applicability using the example use case of integrated
cancer care in section 5.1 and second, assess the Pa2Dmethod in section 5.2.

5.1. Demonstration - the oncology use case
The Pa2D-method was tested by applying it in the
context the large-scale European Joint Action iPAAC
(Innovative Partnership for Action Against Cancer)
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Modell: CRC Patient Pathway Template/Landkarte/CRC_Prozesslandkarte
Stand: Mittwoch, 15. Juli 2020
Bearbeiter:

aiming to develop innovative approaches to advances in
cancer control. One focus is to improve the governance
of integrated cancer care, e.g. by the development and
implementation of patient pathways in comprehensive
cancer care networks (CCCNs). “A CCCN consists of
multiple units belonging to different institutions
dedicated to research, prevention, diagnosis, treatment,
follow-up, supportive and palliative care and
rehabilitation for the benefit of cancer patients and
cancer survivors” [7].
The Pa2D-method was applied to develop a
colorectal cancer patient pathway template for CCCNs
in Europe. The working group for the development of
the template comprised all three roles as specified in
section 4.2. The patient pathway template stakeholders
built an interdisciplinary and international group of
experts in the colorectal cancer domain. The group
comprised people from national and international health
authorities and societies, national care providers
(medical and nursing care) from different CCCN units,
as well as representatives from a European colorectal
cancer patient organization. Therewith, the stakeholders
also included a subgroup of future patient pathway
users. The roles of the patient pathway template
designers and the method experts were taken by the
authors and colleagues, i.e. information systems experts.
In a systematic review process, existing colorectal
cancer pathways and the evidence base (esp. medical
guidelines such as ESMO3 clinical practice guidelines)
for colorectal cancer care were identified. Additionally,
pathways used in the countries and cancer centers of the
working group members were collected.
For the main phase of the patient pathway template
construction (as described in Figure 2), the scope of the
pathway template was defined. It should cover all
phases of CCCN care for patients with a suspicion of
colorectal cancer and for patients with a histologically
confirmed diagnosis. Screening recommendations and
activities of primary prevention should not be
integrated. The scope definition also included the
decision to use BPMN and its domain-specific
extensions [23] for pathway template modeling. With
this, also quality indicators can be added along the
patient pathway. The working progress was organized
remotely for most of the time, having physical meetings
in-between with the whole or part of the working group.
In the next step, the important steps of the patient
pathway template - the process candidates - were
identified and the process landscape was defined (see
Figure 3). It maps the important processes to the
different phases of colorectal cancer care in a CCCN but
does not describe relationships between them.

3

CCCN Entry

Diagnosis

Treatment planning

histological
confirmation

staging diagnostics

pre-therapeutic
MDT meeting

patient consultation

preparation of MDT
meeting

patient consultation
after diagnosis

referral to other
discipline

information processing
and discussion (patient)
shared
decision-making

Treatment
neoadjuvant
radio(chemo)therapy

Follow-up

Rehabilitation

follow-up planning

rehabilitation

follow-up care,
Figuresurgery
3. Process landscape
defined for CCCN
surveillance
care for colorectal cancer patients (excerpt)
adjuvant
chemotherapy

organise patient life
during follow-up

Supportive care

For each process, the input sheets were filled
in by the
supportive care
domain
of the working group and based on the
otherexperts
therapy
current evidence as identified with the evidence review
process.
This information was then used to detail the
palliation
of CCCN care
End-of-life care
single processes if End
necessary
and to develop
a process
post-operative/ mid-/
end of follow-up
post-therapeutic
MDT
model
of the patient
pathway
template
using
a
BPMN.io
consultation
meeting
end-of-life care
modeling environment adapted to patient pathway
organisation of patient
specific
[23], [28] as presented in Figure
life duringrequirements
treatment
4. Quality indicators were included as blue circles and
adaptation notes as comments to the corresponding
1 von 1
pathway concepts. The working groupSeiteregarded
comments as sufficient, practical solution for the
purpose of adaptation notes. A draft of the template was
continuously reviewed by the members of the working
group as well as by external domain experts not
involved in the development process with background
in medical guideline development for the addressed
tumor entity until no further revisions were necessary.
Then, the template was finally approved. It will be
implemented in two pilot CCCNs in Germany and
Poland. The implementation and adaptation process will
be evaluated and changes to the method might be
necessary. After this, the template will function as
recommended patient pathway for colorectal cancer
patients in European CCCNs.

5.2. Assessment of the Pa2D-method
After the demonstration of the Pa2D-method’s
feasibility by using the colorectal cancer use case in
section 5.1, we assess its procedure and its results (the
patient pathway template) regarding the fulfillment of
the initially defined requirements R1 to R7 (see section
3). Reflecting on the experiences from the application of
the method, we argue the completeness of fulfilling each
requirement in Table 4. Additionally, the assessment

ESMO: European Society for Medical Oncology
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Figure 4. Detail of the colorectal cancer patient pathway template for CCCNs
results of the six completed questionnaires received
from the working group are included in Table 4.
In terms of meeting the initially defined
requirements, most of them are strongly positive. The
results regarding R4 and R5 indicate potentials for
stronger implementation in the Pa2D-method. The group
processes could be guided in more detail (relating to
R4). For example, the consensus procedures could be
pre-defined in the method or examples for how to handle
different opinions in the working group could be given.
In the demonstration case, this was not necessary and
the Pa2D-method in its current version assigns the
responsibility for defining the consensus procedure to
the users. The results regarding R5 show that the
inclusion of the evidence base could be improved. The
Pa2D-method uses the existing evidence base as a major
input and complements it with expert knowledge and
experiences. In the demonstration case, there were no
contradictions identified. However, it is important to
keep in mind, that the patient pathway template contents
should be developed based on best available evidence.
This is not possible for all steps and phases in the
pathway, since scientific studies and medical guidelines
are rather available for the medical perspective. The
specification of the nursing, supportive care or patient
perspective is largely based on good practice
experiences from the domain experts.
In summary, the procedure of the Pa2D-method for
the development of patient pathway templates was well
accepted and rated positively. We asked the members of
the working group for their opinion on both what they
liked about the procedure for patient pathway template
construction and how it could be further improved. The

“openness to engage with patient organizations” as well
as the “international, inter-disciplinary and multi-level
consultations”, “compris[ing] multi-sectoral and multinational experience” were highly appreciated. It was
highlighted that the Pa2D-method template development
procedure is a “positive interactive process which
should assist in creating a clear template for different
countries to adapt according to their specific needs but
which is at the same time based on evidence”. The
process was rated “rigorous and well thought-through”.
The template-based approach was in general well
accepted and is expected to have a positive impact
especially on creating a uniformly high level of quality
care, on reducing the risks and difficulties of patient
pathway development for comprehensive care
networks, on improving the quality of patient pathways
implemented in comprehensive care networks, as well
as on improving benchmarking of comprehensive care
networks for the same patient populations. Potentials for
improvement of the method were stated in terms of
increasing the number of meetings (physical or online)
to discuss intermediate results. The transparent
communication of the planned development procedure
in the beginning of the project is said to be of high
importance. “[P]iloting [the template] will show
bottlenecks” of the method. Then, other possible
improvements might become apparent.

6. Discussion
We used a user-centered and requirements-driven
approach to design the Pa2D-method to practically
support the development and implementation of patient
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Table 4. Requirements-based evaluation of the
Pa2D-method (1: strongly agree to 5: strongly
disagree)
Working group
No. Fulfillment
assessment
R1
R1 Separation of template
5
development and its implementation (templatebased development of a
1
0 0 0 0
PP for specific CCN);
template construction 1 2 3 4 5 NA
specified as main phase
R2
R2 A PP template is
4
developed for a specific
disease, specified by in2
and exclusion criteria in
0 0 0 0
the scope definition of
the template construc- 1 2 3 4 5 NA
tion phase
R3
R3 Interdisciplinary multi6
stakeholder group is
defined in the role
model; covers different
0 0 0 0 0
professions and knowledge domains of all PP 1 2 3 4 5 NA
stages and CCN units
R4
R4 The group composition 2 2
and consensus finding
1
1
process are defined in
the project institution
0 0
phase for the PP
1 2 3 4 5 NA
template development
R5 Systematic collection of
R5
evidence as separate
4
phase; PP template construction uses current
evidence base; recom1 1
0 0 0
mended modeling languages provide concepts 1 2 3 4 5 NA
for representation of
evidence in PP models
R6
R6 Obligatory and optional 5
concepts are defined
with annotations in the
1
PP template model;
0 0 0 0
adaptation notes are
1 2 3 4 5 NA
described
R7
R7 Patient representatives
3 3
are explicitly included
as
PP
template
stakeholders; a patient
0 0 0 0
view with specific tasks
is included in the PP 1 2 3 4 5 NA
template (BPMN lane)
pathways in comprehensive care networks. The method

pathways in comprehensive care networks. The method
provides the description of roles to be involved and
describes a template-based patient pathway
development procedure. The method was assessed by
demonstrating its applicability with the use case of
oncology care. A patient pathway template for
colorectal cancer was developed by in international,
interdisciplinary multi-stakeholder working group, who
positively assessed the method based on their
experiences with the development process.
Critically reflecting on the limitations of our
approach, the requirements used for the method
development might not be complete. Further
requirements might lead to changes in the Pa2D-method
design. However, the requirements are supported by the
findings of a former literature review on the topic of
methodological support for patient pathway
development in [9]. Also, the Pa2D-method fits into the
existing literature on methodological support for the
development and implementation of pathways in
healthcare. It includes, combines and especially details
the necessary steps described in other literature (e.g.
referring to [8], [10]–[13]). Reflecting on the application
and evaluation of the Pa2D-method, it needs to be
applied for more cases than the one we demonstrated in
section 5. It is currently also applied for the
development of a pancreatic cancer patient pathway
template but should also be used and tested outside of
the oncology care domain in the future. Also, the
implementation and adaptation of the template in
specific comprehensive care networks will be necessary
to demonstrate and evaluate the method in a more
comprehensive manner. This will be conducted with
both the colorectal and pancreatic patient pathway
template in pilot CCCNs in Germany and Poland. A
long-term evaluation of implemented patient pathways
is desirable as well. Currently, the evaluation of
pathways and their impact is rather on outcomes such as
time, resources and costs [29]. With the patient pathway
approach, rather patient- and network-centered
evaluation approaches are needed - including outcome
measures concerning patient and disease progression
(e.g. disease management, quality of life, patient
empowerment), coordination, or communication, which
characterize integrated care [30].

7. Conclusion
With the Pa2D-method, we provide practical
guidance for the development and implementation of
patient pathways in comprehensive care networks.
Designing the method, a user-driven and requirementsbased procedure was followed. The template-based
approach for patient pathway development aims to
support uniformly high quality for comprehensive care
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networks and to simplify and standardize the
development process. The Pa2D-method was already
tested in the field of oncology care by developing a
patient pathway template for colorectal cancer care in
CCCNs. A template for pancreatic cancer is under
development. After implementing the templates in two
European pilot CCCNs and thus, further testing and
potentially improving the method itself, the Pa2Dmethod will become part of the certification program in
European cancer care. This underlines its high
innovation and dissemination potentials. The work
pushes standardized patient pathway development and
the large-scale implementation in comprehensive care
networks – thus, supporting the implementation of
integrated care. The Pa2D-method can increase the
usage of patient pathways in care practice and serve as
basis for their evaluation.
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